References
- Kipp M, Nyamoya S, Hochstrasser T, et al. Multiple sclerosis animal models: a clinical and histopathological perspective. Brain Pathol. 2017;27(2):123–137.
- Martinelli Boneschi F, Vacchi L, Rovaris M, et al. Mitoxantrone for multiple sclerosis. Cochrane Database Syst Rev. 2013;31(5):CD002127.
- Montalban X, Hauser SL, Kappos L, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med. 2017;376(3):209–220.
- DePaula-Silva AB, Hanak TJ, Libbey JE, et al. Theiler’s murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: models for multiple sclerosis and epilepsy. J Neuroimmunol. 2017;308:30–42.
- Hoflich KM, Beyer C, Clarner T, et al. Acute axonal damage in three different murine models of multiple sclerosis: a comparative approach. Brain Res. 2016;1650:125–133.
- Chan D, Binks S, Nicholas JM, et al. Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial. Lancet Neurol. 2017;16(8):591–600.
- Wolinsky JS, Narayana PA, O’Connor P, et al. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol. 2007;61(1):14–24.
- van Munster CE, Uitdehaag BM. Outcome measures in clinical trials for Multiple Sclerosis. CNS Drugs. 2017;31(3):217–236.
- Praet J, Guglielmetti C, Berneman Z, et al. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. Neurosci Biobehav Rev. 2014;47:485–505.
- MacKenzie-Graham A, Rinek GA, Avedisian A, et al. Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging. Neuroimage. 2012;60(1):95–104.
- Wood TC, Simmons C, Hurley SA, et al. Whole-brain ex-vivo quantitative MRI of the cuprizone mouse model. Peer J. 2016;4:e2632.
- Dorman CW, Krug HE, Frizelle SP, et al. A comparison of DigiGait and TreadScan imaging systems: assessment of pain using gait analysis in murine monoarthritis. J Pain Res. 2014;7:25–35.
- Kipp M, Kiessling MC, Hochstrasser T, et al. Design-based stereology for evaluation of histological parameters. J Mol Neurosci. 2017;61(3):325–342.
- Vogt J, Paul F, Aktas O, et al. Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis. Ann Neurol. 2009;66(3):310–322.
- Crawford DK, Mangiardi M, Xia X, et al. Functional recovery of callosal axons following demyelination: a critical window. Neuroscience. 2009;164(4):1407–1421.
- Scheld M, Ruther BJ, Grosse-Veldmann R, et al. Neurodegeneration triggers peripheral immune cell recruitment into the forebrain. J Neurosci. 2016;36(4):1410–1415.
- Ruther BJ, Scheld M, Dreymueller D, et al. Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression. Glia. 2017 Dec;65(12):1900-1913.